Nathalie Beauregard

Nathalie Beauregard, Partner, Corporate

Contact Information

  • tel: 514.904.8121
Download V-Card

Areas of Expertise

Bar Admission

Québec, 1989 ; New York, 1989

Education

  • HEC (Paris) and New York University (Stern), M.B.A.
  • McGill University, B.C.L., LL.B.

Office

Montréal

Language(s)

English, French

Biography

Nathalie is a partner in the Corporate Practice Group. Her practice focuses on financings, mergers and acquisitions transactions and strategic commercial matters. She acts for a broad spectrum of companies including businesses established to commercialize newly acquired technologies. Her practice also includes negotiating and advising in respect of national and international strategic alliances, licensing, distribution, development research, government contracts, procurement, franchising and other similar commercial arrangements. She regularly helps businesses create employment arrangements for their employees and senior executives and advises companies and boards of directors on their executive hires and terminations.

As an adviser to many venture capital funds, Nathalie has been involved in numerous cross-border private financings and mergers and acquisitions transactions.

Nathalie is also a founding member of Réseau Anges Québec.

Notable Matters

  • Laboratories Casen Fleet S.L.U. in its distribution agreement with a Canadian distributor.
  • AngioChem Inc. in its commercial agreements and convertible debt and preferred share financings.
  • Mimetogen Pharmaceuticals, Inc. in its financing and its commercial matters.
  • Milestone Pharmaceuticals, Inc. in its $12.5 million Class A1 round of financing and its commercial matters.
  • Resonant Medical Inc. in its sale to Elekta AB (publ), its financing, licensing and distribution agreements as well as all corporate or employment and labour matters.
  • Ambrilia Pharmaceuticals, Inc. in its out-licensing agreement to TaiMed Biologica Inc.
  • Topigen Pharmaceuticals, Inc. in its sale to Pharmaxis Ltd. of Australia and its concurrent financing of $3.6 million.
  • Victhom Human Bionics Inc. in its transfer of all of its assets of Neurobionix division to a newly created joint venture with a concurrent total equity investment by Otto Bock of $30 million in the joint venture and the negotiation of its distribution agreement with Otto Bock.
  • Kaneq Pharma Inc. in its financing and commercial matters.
  • Caxton Advantage Life Sciences Fund LP, in its financing in Geminix Pharmaceuticals for
    20 million dollars.
  • Anges Québec in the formation of Anges Québec Capital.
  • Landis+Gyr in the negociation of its $400 million contract for the sale of metering system to Hydro-Québec Inc.
  • Régie municipale de l’énergie Gaspésie – Iles-de-la-Madeleine, in relation to the formation of a limited partnership in order to operate wind farms in Quebec.
  • Lipso Systems Inc. in its sale to Transcontinental Inc. and other commercial or corporate issues.
  • Accedian Networks Inc., in its Class C and B exchangeable share financings and commercial and corporate matters.
  • Fonds de solidarité du Québec in the financing of the management buy-out of TeraXion Inc.Desjardins Capital de risque in its financing of the management buy-out of Spectrum Inc.
  • Yotta Yotta Inc. in its financings and subsequent sale to EMC Corporation.
  • Rho Capital Ventures Inc. and Braemar Energy Inc. in its financings of Enerkem Inc. for an aggregate amount of more than $90 million.

Affiliations

  • Canadian Bar Association
  • Association of Québec Women in Financial, member of the Developement and professional advancement committee from 2005 to 2011
  • Association of MBA of Québec
  • Canadian Venture Capital Association
  • Canadian IT Law Association

Industry Recognition

  • The Canadian Legal Lexpert Directory 2012: Technology Transactions 

Publications/Events/Education

  • National Assembly introduces Integrity in Public Contracts Act, Osler Update, November 12, 2012.
  • Proposed changes to pharmacy act will clarify the scope of activities that can be performed by pharmacists, Health Law in Canada, volume 33 no. 1, written with in collaboration with Carine Bouzaglou and Timour Breslavski. August 2012.
  • Gift Card Legislation Introduced in Québec, Osler Franchise Review, May 2011.
  • Amendments to the consumer protection legislation, Osler Franchise Review, May 2010.
  • The Charter of the French language and websites, Osler Franchise Review, October 2009.
  • Nathalie regularly gives workshops on term sheets for group of investors.
  • Nathalie gave a conference at the University of Sherbrooke (MBA / Entrepreneurship), February 21, 2011, on "Cours introductif sur le droit des compagnies" and was speaker at "Journées d’études fiscales" organized by the Canadian Tax Foundation , McGill University and the Canadian Bar Association in June 2010 on "Les conventions entre actionnaires, aspects corporatifs et fiscaux". The text of the conference is published by the Canadian Tax Foundation in TaxFind Online.

Pro Bono/Community Work

  • Nathalie has been a member of the board of directors of Réseau Anges Québec from 2008 to 2012. 
  • Nathalie is a member of the board of directors of Accélérateur de création d'entreprises technologiques ("ACET"), since 2010 and of the board of directors of Galerie d'art d’Outremont since 2011.
  • Nathalie is an ambassador of Arion Baroque Orchestra and was a member of the board of directors of the Arion Baroque Orchestra Foundation from 2007 to 2010.
  • Nathalie seats on advisory committees of several start-up companies.
  • Nathalie is Governor of the "Fondation du Barreau du Québec" and of the "Fondation de recherche en administration de l’Université de Sherbrooke".
  • Nathalie is a member of the organizational committee of the "Fête Champêtre 2013" of the Fondation Armand-Frappier. 

Downloadable Profile

Nathalie Beauregard